Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells

Blood

Volumn 92, Issue 3, 1998, Pages 996-1002

  Clément, Marie Véronique ^a   Hirpara, Jayshreekumari L ^a   Chawdhury, Sanaul Haq ^a   Pervaiz, Shazib ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLSERINE; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

EID: 0345566753     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.3.996.415k23_996_1002     Document Type: Article

References (29)

1. Nonomura S, Kanagawa H, Makimoto A: Chemical constituents of polygonaceous plants. I. Studies on the components of K0-jo-kon. (Polygonum cuspidatum SIEB et ZUCC). Yakugaku Zasshi 83:988, 1963
2. Kubo M, Kimura Y, Shin H, Haneda T, Tani T, Namba K: Studies on the antifungal substance of crude drug (II). On the roots of Polygonum cupsidatum Sieb et Zucc (Polygonaceae). Shoyakugaku Zashi 35:58, 1981
3. Soleas GJ, Diamandis EP, Goldberg DM: Resveratrol: A molecule whose time has come? and gone? Clin Biochem 30:91, 1997
4. Rimm EB, Klatsky A, Grobbee D, Stampfer MJ: Review of moderate alcohol consumption and reduced risk of coronary heart disease: Is the effect due to beer, wine, or spirits? Br Med J 312:731, 1996
5. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, Van Denburgh M, Willett W, Hennekens CH: Moderate alcohol intake, increased levels of low density Upoprotein and its subfractions and decreased risk of myocardial infarction. N Engl J Med 329:1829, 1993
6. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM: The red wine phenolics trans resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clin Chim Acta 235:207, 1995
7. Frankel EN, Waterhouse AL, Kinsella JE: Inhibition of human LDL oxidation by reveratrol. Lancet 341:1103, 1993
8. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218, 1997
9. O'Brien MC, Healy SF Jr, Raney SR, Hurst JM, Avner B, Hanly A, Mies C, Freeman JW, Snow C, Koester SK, Bolton WE: Discrimination of late apoptotic/necrotic cells (type III) by flow cytometry in solid tumors. Cytometry 28:81, 1997
10. Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, Greil R: Drug-induced apoptosis is associated with enhanced Fas(Apo1/CD95) ligand expression but occurs independently of Fas(Apo-1/ CD95) signaling in human T-acute lymphatic leukemia cells. Cancer Res 57:3331, 1997
11. Kaufman SH: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptotecin, and other cytotoxic anticancer drugs: Cautionary note. Cancer Res 49:5870, 1989
12. Connor J, Pak CC, Schroit AJ : Exposure of phosphatidylserine in the outer leaflet of human red cells. Relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 28:2399, 1994
13. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader J, van Schie RCAA, LaFace DM, Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus. Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182:1545, 1995
14. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers recognition and removal by macrophages. J Immunol 148:2207, 1992
15. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuian J: Human ICE/CED-3 protease nomenclature. Cell 87:171, 1996
16. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin 1b converting enzyme. Cell 75:641, 1993
17. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J: Induction of apoptosis in fibroblasts by interleukin l b-converting enzyme, a mamalian homolog of the C. elegans cell death gene ced-3. Cell 75:653, 1993
18. Lazebnick YA, Kaufman SH, Desnoyers S, Poirier GG, Earnshaw WC: Cleavage of poly (ADP-ribose) polymerase by the proteinase with properties like ICE. Nature 371:346, 1994
19. Kaufman SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG: Specific proteolytic cleavage of poly (ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976, 1993
20. Friesen C, Herr I, Krammer PH, Debatin K-M: Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2:574, 1996
21. Muller M, Strand S, Hug H, Heinemann E-M, Walczak H, Hofmann WJ, Stremmel W, Krammer PH, Galle PR: Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild type p53. J Clin Invest 99:403, 1997
22. Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM: The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 57:3823, 1997
23. Micheau O, Solary E, Hammann A, Martin F, Dimanche-Boitrel M-T: Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity. J Natl Cancer Inst 89:783, 1997
24. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N: Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 149:3753, 1992
25. Suda T, Takahashi T, Goldstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
26. Trauth BC, Klas C, Peters AJM, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301, 1989
27. Rensing-Ehl A, Frei K, Flury R, Matiba B, Mariani SM, Weller M, Aebischer P, Krammer PH, Fontana A: Local Fas/Apo-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur J Immunol 25:2253, 1995
28. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rouke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer HP, Peter ME, Dixit V: FLICE, a novel FADD-homologous to ICE/CED-3-Iike protease, is recruited to the CD95(Fas/Apo-1) death-inducing signaling complex. Cell 85:817, 1996
29. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS, Flavell RA: Altered cytokine export and apoptosis in mice deficient in interleukin 1b converting enzyme. Science 267:2000, 1995